JP2012507988A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507988A5
JP2012507988A5 JP2011534924A JP2011534924A JP2012507988A5 JP 2012507988 A5 JP2012507988 A5 JP 2012507988A5 JP 2011534924 A JP2011534924 A JP 2011534924A JP 2011534924 A JP2011534924 A JP 2011534924A JP 2012507988 A5 JP2012507988 A5 JP 2012507988A5
Authority
JP
Japan
Prior art keywords
oligonucleotide
seq
vegf antibody
allele
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011534924A
Other languages
English (en)
Japanese (ja)
Other versions
JP5701216B2 (ja
JP2012507988A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/063434 external-priority patent/WO2010054110A2/en
Publication of JP2012507988A publication Critical patent/JP2012507988A/ja
Publication of JP2012507988A5 publication Critical patent/JP2012507988A5/ja
Application granted granted Critical
Publication of JP5701216B2 publication Critical patent/JP5701216B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011534924A 2008-11-05 2009-11-05 加齢黄斑変性における遺伝的多型 Expired - Fee Related JP5701216B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11166708P 2008-11-05 2008-11-05
US61/111,667 2008-11-05
US17485609P 2009-05-01 2009-05-01
US61/174,856 2009-05-01
PCT/US2009/063434 WO2010054110A2 (en) 2008-11-05 2009-11-05 Genetic polymorphisms in age-related macular degeneration

Publications (3)

Publication Number Publication Date
JP2012507988A JP2012507988A (ja) 2012-04-05
JP2012507988A5 true JP2012507988A5 (enExample) 2014-09-18
JP5701216B2 JP5701216B2 (ja) 2015-04-15

Family

ID=41650496

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011534924A Expired - Fee Related JP5701216B2 (ja) 2008-11-05 2009-11-05 加齢黄斑変性における遺伝的多型

Country Status (14)

Country Link
US (2) US20120003641A1 (enExample)
EP (2) EP2356250A2 (enExample)
JP (1) JP5701216B2 (enExample)
KR (1) KR101719376B1 (enExample)
CN (2) CN103333952B (enExample)
AU (1) AU2009313475B2 (enExample)
CA (1) CA2740242A1 (enExample)
DK (1) DK2540843T3 (enExample)
ES (1) ES2498274T3 (enExample)
IL (1) IL211995A (enExample)
MX (1) MX2011004763A (enExample)
PL (1) PL2540843T3 (enExample)
SI (1) SI2540843T1 (enExample)
WO (1) WO2010054110A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20170001A (es) 2008-04-28 2017-08-10 Genentech Inc Anticuerpos anti factor d humanizados
US10337071B2 (en) 2008-07-25 2019-07-02 National Cancer Center Oncogene NRF2
US20130330341A1 (en) * 2011-02-23 2013-12-12 Sanofi Single nucleotide polymorphisms in the promoter of vegfa gene and their use as predictive markers for anti-vegf treatments
JO3283B1 (ar) 2011-04-26 2018-09-16 Sanofi Sa تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI)
WO2012159089A1 (en) 2011-05-19 2012-11-22 Sequenom, Inc. Products and processes for multiplex nucleic acid identification
MX2014002144A (es) * 2011-08-26 2014-03-31 Hoffmann La Roche Metodo para predecir el beneficio clinico del tratamiento de los transtornos del desarrollo neurologico, neurologicos o neuropsiquiatricos.
PE20141562A1 (es) * 2011-10-14 2014-11-12 Genentech Inc Anticuerpos anti-htra1 y metodos de uso
US20140004105A1 (en) * 2012-06-29 2014-01-02 Sequenom, Inc. Age-related macular degeneration diagnostics
MX2016001854A (es) * 2013-08-12 2016-09-06 Genentech Inc Composiciones y metodo para tratar condiciones asociadas con el complemento.
SG11201608868PA (en) 2014-05-01 2016-11-29 Genentech Inc Anti-factor d antibody variants and uses thereof
WO2015200905A2 (en) 2014-06-28 2015-12-30 Oligasis, Llc Dual pdgf/vegf antagonists
RS58957B1 (sr) 2014-07-18 2019-08-30 Sanofi Sa Postupak za predviđanje ishoda tretmana sa afliberceptom kod pacijenta za kog se sumnja da boluje od raka
CN106999559A (zh) * 2014-12-19 2017-08-01 儿童医院医疗中心 与移植相关血栓性微血管病相关的方法和组合物
CA2983224A1 (en) 2015-04-24 2016-10-27 Agena Bioscience, Inc. Multiplexed method for the identification and quantitation of minor alleles and polymorphisms
CN104878105B (zh) * 2015-06-02 2017-10-31 北京医院 一种预测雷珠单抗治疗年龄相关性黄斑变性疗效的试剂
CN104894261B (zh) * 2015-06-02 2020-02-14 北京医院 一种预测雷珠单抗治疗年龄相关性黄斑变性疗效的试剂盒
TW201730211A (zh) 2015-10-30 2017-09-01 建南德克公司 抗因子d抗體及結合物
JP2018536650A (ja) 2015-10-30 2018-12-13 ジェネンテック, インコーポレイテッド 抗d因子抗体変異体コンジュゲート及びその使用
IL290457B2 (en) 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
WO2017148904A1 (en) * 2016-02-29 2017-09-08 Franz Grus Predictive markers useful in the treatment of wet age-related macular degeneration
JP7179721B2 (ja) 2016-06-21 2022-11-29 オリオン・オフサルモロジー・エルエルシー 複素環式プロリンアミド誘導体
JP7164521B2 (ja) 2016-06-21 2022-11-01 オリオン・オフサルモロジー・エルエルシー 炭素環式プロリンアミド誘導体
CA3092588A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
CN113373236B (zh) * 2021-02-19 2021-12-31 中国科学院北京基因组研究所(国家生物信息中心) 一种获得中国人群个体年龄的方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8311018D0 (en) 1983-04-22 1983-05-25 Amersham Int Plc Detecting mutations in dna
US4998617A (en) 1986-09-15 1991-03-12 Laura Lupton Inc Facial cosmetic liquid make up kit
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US6270961B1 (en) 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
US5176996A (en) 1988-12-20 1993-01-05 Baylor College Of Medicine Method for making synthetic oligonucleotides which bind specifically to target sites on duplex DNA molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use
US5256775A (en) 1989-06-05 1993-10-26 Gilead Sciences, Inc. Exonuclease-resistant oligonucleotides
FR2650840B1 (fr) 1989-08-11 1991-11-29 Bertin & Cie Procede rapide de detection et/ou d'identification d'une seule base sur une sequence d'acide nucleique, et ses applications
US5264564A (en) 1989-10-24 1993-11-23 Gilead Sciences Oligonucleotide analogs with novel linkages
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
US6004744A (en) 1991-03-05 1999-12-21 Molecular Tool, Inc. Method for determining nucleotide identity through extension of immobilized primer
US5858659A (en) 1995-11-29 1999-01-12 Affymetrix, Inc. Polymorphism detection
US5952172A (en) 1993-12-10 1999-09-14 California Institute Of Technology Nucleic acid mediated electron transfer
US5968740A (en) 1995-07-24 1999-10-19 Affymetrix, Inc. Method of Identifying a Base in a Nucleic Acid
DE69829891T2 (de) 1997-04-07 2005-10-06 Genentech, Inc., South San Francisco Anti-VEGF Antikörper
CA2303206A1 (en) 1997-09-10 1999-03-18 University Of Maryland, Baltimore Method of amplifying dna and rna mismatch cleavage products
CA2588270A1 (en) * 2004-11-18 2006-06-15 Yale University Methods and compositions for treating ocular disorders
US7972787B2 (en) * 2007-02-16 2011-07-05 Massachusetts Eye And Ear Infirmary Methods for detecting age-related macular degeneration

Similar Documents

Publication Publication Date Title
RU2015101034A (ru) Генетические полиморфизмы при возрастной дегенерации желтого пятна
US20220206001A1 (en) Methods and systems for detecting coronavirus
EP4142784A2 (en) Variant nucleic acid libraries for coronavirus
JP2009541204A5 (enExample)
JP2020526478A5 (enExample)
JP2011528561A5 (enExample)
JP2007510664A5 (enExample)
JP2015212281A5 (enExample)
RU2009120052A (ru) Композиции и способы связывания сфингозин-1-фосфата
JP2016516400A5 (enExample)
RU2015126533A (ru) Анти-cd47 антитела и способы их применения
CA2938731A1 (en) Methods of treating alzheimer's disease
JP2021501744A5 (enExample)
CN106536754A (zh) 用il‑13拮抗剂选择性治疗哮喘的方法
JP2010533495A5 (enExample)
NZ602621A (en) Antibodies against csf-1r
JP2009539348A5 (enExample)
JP2017507130A5 (enExample)
JP2022525377A5 (enExample)
JP2018518151A5 (enExample)
JP2020537520A5 (enExample)
RU2013153592A (ru) Анти-mif антитела
JP2011527899A5 (enExample)
JP2019534892A5 (enExample)
EP2635704A1 (en) Predicting progression to advanced age-related macular degeneration using a polygenic score